Figure 6. DDX5 promote gastric cancer cells progression in vivo via circPHF14. (A) Tumor growth curves of AGS xenografts in nude mice. Group 1, 2, 3 mice were injected with DDX5, NC, DDX5 and si-circPHF14 cells, respectively. (B–D) Xenograft tumors collected on day 30 post subcutaneous implantation.